RxDoctor Payments Data

Erin Berry

Obstetrics & Gynecology · Seattle, WANPI 1619130556

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $30 of the $49 with a category attached, or 60.7%. Medicines360 accounts for 60.7% of it on its own, with 1 other manufacturer making up the rest. That places this record below the midpoint for obstetrics & gynecology clinicians in WA, where the typical reported total is $172.

$49in general payments, 2019–2025

Across 2 payments — averaging $24.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medicines360$30
  • Boston Scientific$19
$1,288,979in research payments, 2019–2025

Across 215 payments — averaging $5995.25 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Ortho-clinical Diagnostics, Inc.$515K
  • Abbott$197K
  • Cepheid$195K
  • Organon$189K
  • Evofem Biosciences, Inc.$88K
  • Bayer$40K
  • plus $66K from 2 others

What the payments were for

  • Consulting fees$3061%
  • Food & beverage$1939%

General payments by program year

21
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Medicines3601$30
Boston Scientific1$19

How this compares

$49 in reported general payments places this provider in the 25th percentile of 733 obstetrics & gynecology providers in Washington.

See all obstetrics & gynecology providers in Washington

Other obstetrics & gynecology in Seattle

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →